ProSperACC-1: Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer (clinicaltrials.gov) - Jan 12, 2023 - P1 | N=56 | Recruiting | Sponsor: University Hospital Tuebingen | Not yet recruiting ➔ Recruiting
Enrollment open • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|